Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in BMJ

Retrieve available abstracts of 53 articles:
HTML format
Text format

Single Articles

    February 2017

  1. Atrial fibrillation stroke worse in women . . . and other stories.
    BMJ. 2017;356:j819.
    PubMed     Text format    

  2. NIELSEN PB, Skjoth F, Sogaard M, Kjaeldgaard JN, et al
    Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2017;356:j510.
    PubMed     Text format     Abstract available

  3. WISE J
    Multiple pregnancies may increase a woman's risk of atrial fibrillation.
    BMJ. 2017;356:j609.
    PubMed     Text format    

    November 2016
  4. MAYOR S
    More than half of stroke patients were not given preventive drugs, study finds.
    BMJ. 2016;355:i6105.
    PubMed     Text format    

  5. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    PubMed     Text format     Abstract available

    October 2016
    Optimal dosing of rivaroxaban is undefined.
    BMJ. 2016;355:i5549.
    PubMed     Text format    

    Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ. 2016;355:i5362.
    PubMed     Text format    

    August 2016
  8. WISE J
    Most patients taking warfarin do not maintain stable INR values.
    BMJ. 2016;354:i4402.
    PubMed     Text format    

    June 2016

  9. QT interval and drug therapy.
    BMJ. 2016;353:i2732.
    PubMed     Text format    

  10. DUKES JW, Dewland TA, Vittinghoff E, Olgin JE, et al
    Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws.
    BMJ. 2016;353:i2714.
    PubMed     Text format     Abstract available

    January 2016
  11. EMDIN CA, Wong CX, Hsiao AJ, Altman DG, et al
    Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.
    BMJ. 2016;532:h7013.
    PubMed     Text format     Abstract available

    No link between macrolide antibiotics and ventricular arrhythmias, study finds.
    BMJ. 2016;352:i1083.
    PubMed     Text format    

  13. FERRO A
    Newer antiplatelet agents in acute coronary syndrome.
    BMJ. 2016;352:h7025.
    PubMed     Text format    

  14. GALE CP, Camm AJ
    Assessment of palpitations.
    BMJ. 2016;352:h5649.
    PubMed     Text format    

    Decisions on restarting anticoagulation should be made earlier after rebleeding.
    BMJ. 2016;532:i248.
    PubMed     Text format    

  16. STAERK L, Lip GY
    Authors' reply to Beales.
    BMJ. 2016;532:i266.
    PubMed     Text format    

  17. WANG SV, Franklin JM, Glynn RJ, Schneeweiss S, et al
    Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.
    BMJ. 2016;353:i2607.
    PubMed     Text format     Abstract available

  18. COHEN D
    Rivaroxaban: can we trust the evidence?
    BMJ. 2016;352:i575.
    PubMed     Text format    

  19. WISE J
    Atrial fibrillation in women is linked to increased risk of cancer.
    BMJ. 2016;353:i2982.
    PubMed     Text format    

  20. WISE J
    Telling patients of incidental genetic findings is questionable, researchers warn.
    BMJ. 2016;352:h7034.
    PubMed     Text format    

  21. JASPERS FOCKS J, Brouwer MA, Wojdyla DM, Thomas L, et al
    Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
    BMJ. 2016;353:i2868.
    PubMed     Text format     Abstract available

  22. LARSEN TB, Skjoth F, Nielsen PB, Kjaeldgaard JN, et al
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2016;353:i3189.
    PubMed     Text format     Abstract available

  23. INGHAMMAR M, Svanstrom H, Melbye M, Pasternak B, et al
    Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
    BMJ. 2016;352:i843.
    PubMed     Text format     Abstract available

  24. MOORE M, Hopkins J, Wainwright P
    Primary care management of patients after weight loss surgery.
    BMJ. 2016;352:i945.
    PubMed     Text format    

  25. BRADLEY SM, Liu W, Chan PS, Nallamothu BK, et al
    Defibrillation time intervals and outcomes of cardiac arrest in hospital: retrospective cohort study from Get With The Guidelines-Resuscitation registry.
    BMJ. 2016;353:i1653.
    PubMed     Text format     Abstract available

  26. COUPER K, Perkins GD
    Improving outcomes from in-hospital cardiac arrest.
    BMJ. 2016;353:i1858.
    PubMed     Text format    

  27. ODUTAYO A, Wong CX, Hsiao AJ, Hopewell S, et al
    Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    BMJ. 2016;354:i4482.
    PubMed     Text format     Abstract available

    Small amounts of alcohol increase risk of atrial fibrillation, study finds.
    BMJ. 2016;354:i5041.
    PubMed     Text format    

  29. MAHTANI KR, Heneghan C
    Novel oral anticoagulants for atrial fibrillation.
    BMJ. 2016;354:i5187.
    PubMed     Text format    

  30. MONTASTRUC F, Montastruc G, Montastruc JL, Revet A, et al
    Cardiovascular safety of methylphenidate should also be considered in adults.
    BMJ. 2016;353:i3418.
    PubMed     Text format    

    January 2015
  31. JUN M, Hemmelgarn BR
    Authors' reply to Williams.
    BMJ. 2015;350:h1582.
    PubMed     Text format    

    Problems with using numbers needed to harm.
    BMJ. 2015;350:h1581.
    PubMed     Text format    

    Contact with pharmacist can improve adherence to new anticoagulant, study finds.
    BMJ. 2015;350:h1954.
    PubMed     Text format    

    Safety of new oral anticoagulants.
    BMJ. 2015;350:h1679.
    PubMed     Text format    

  35. CHANG HY, Zhou M, Tang W, Alexander GC, et al
    Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    BMJ. 2015;350:h1585.
    PubMed     Text format     Abstract available

  36. ABRAHAM NS, Singh S, Alexander GC, Heien H, et al
    Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    BMJ. 2015;350:h1857.
    PubMed     Text format     Abstract available

  37. CHEN CY, Stevenson LW, Stewart GC, Bhatt DL, et al
    Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    BMJ. 2015;351:h3529.
    PubMed     Text format     Abstract available

    Effective antidotes for new anticoagulants.
    BMJ. 2015;350:h2775.
    PubMed     Text format    

  39. XIAN Y, Wu J, O'Brien EC, Fonarow GC, et al
    Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study.
    BMJ. 2015;351:h3786.
    PubMed     Text format     Abstract available

  40. LEWIS LS
    Meta-analysis should not be subject to selectivity and imbalance.
    BMJ. 2015;350:h3337.
    PubMed     Text format    

  41. WEBB RH, Grant C, Harnden A
    Acute rheumatic fever.
    BMJ. 2015;351:h3443.
    PubMed     Text format    

  42. LOVELL B, Connor H
    Twelve lead electrocardiography after collapse.
    BMJ. 2015;351:h3512.
    PubMed     Text format    

  43. MAYOR S
    Abnormal extra heartbeats may be modifiable risk factor for heart failure, study shows.
    BMJ. 2015;351:h3674.
    PubMed     Text format    

    Can patient centered outcomes research improve healthcare?
    BMJ. 2015;351:h3859.
    PubMed     Text format    

  45. MORTON L
    The heart of medicine: growing up with pioneering treatment.
    BMJ. 2015;351:h3881.
    PubMed     Text format    

  46. ZIFF OJ, Lane DA, Samra M, Griffith M, et al
    Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.
    BMJ. 2015;351:h4451.
    PubMed     Text format     Abstract available

    Risk of atrial fibrillation with bisphosphonate treatment.
    BMJ. 2015;351:h5870.
    PubMed     Text format    

  48. COLE GD, Francis DP
    Trials are best, ignore the rest: safety and efficacy of digoxin.
    BMJ. 2015;351:h4662.
    PubMed     Text format    

    Restarting antithrombotic drugs after gastrointestinal haemorrhage in people with atrial fibrillation.
    BMJ. 2015;351:h6104.
    PubMed     Text format    

  50. STAERK L, Lip GY, Olesen JB, Fosbol EL, et al
    Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2015;351:h5876.
    PubMed     Text format     Abstract available

  51. ANDERSEN K, Rasmussen F, Held C, Neovius M, et al
    Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study.
    BMJ. 2015;351:h4543.
    PubMed     Text format     Abstract available

  52. COHEN D
    Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device.
    BMJ. 2015;351:h6431.
    PubMed     Text format    

    January 2014
  53. PLYMEN CM, Carr-White GS, Kapetanakis S
    The Christmas tree sign: a diagnostic tool for ECG connoisseurs.
    BMJ. 2014;349:g7342.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.